Skip to content

Rare Disease Tracker
Most Favored Nation Tracker

Rare Disease Tracker
Most Favored Nation Tracker

Methodology

Imbria Pharmaceuticals, Inc. 18/06/2026

By investmenttrac / June 18, 2026

treatment of symptomatic nonobstructive hypertrophic cardiomyopathy

← Previous Entry

Facebook Linkedin

Main Menu

Home
About
Resources
Podcast
Contact

Scroll to Top